{"id":"https://openalex.org/W2986355124","doi":"https://doi.org/10.14229/jadc.2019.11.12.001","title":"Pharmacokinetic Considerations to Maximize an ADC\u2019s Therapeutic Index","display_name":"Pharmacokinetic Considerations to Maximize an ADC\u2019s Therapeutic Index","publication_year":2019,"publication_date":"2019-11-12","ids":{"openalex":"https://openalex.org/W2986355124","doi":"https://doi.org/10.14229/jadc.2019.11.12.001","mag":"2986355124"},"language":"en","primary_location":{"id":"doi:10.14229/jadc.2019.11.12.001","doi":"https://doi.org/10.14229/jadc.2019.11.12.001","is_oa":true,"landing_page_url":"https://doi.org/10.14229/jadc.2019.11.12.001","pdf_url":null,"source":{"id":"https://openalex.org/S4210211455","display_name":"ADC Review / Journal of Antibody-drug Conjugates","issn_l":"2327-0152","issn":["2327-0152"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ADC Review / Journal of Antibody-drug Conjugates","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.14229/jadc.2019.11.12.001","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037263558","display_name":"Greg M. Thurber","orcid":"https://orcid.org/0000-0001-7570-2080","observed_orcids":["https://orcid.org/0000-0001-7570-2080"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Greg Thurber","raw_affiliation_strings":["University of Michigan"],"raw_orcid":"https://orcid.org/0000-0001-7570-2080","affiliations":[{"raw_affiliation_string":"University of Michigan","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5037263558"],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":null,"apc_paid":null,"fwci":0.1503,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.52547582,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.875},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":1.0},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7480000257492065},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8560000061988831},{"id":"https://openalex.org/keywords/cytotoxin","display_name":"cytotoxin","score":0.7239999771118164},{"id":"https://openalex.org/keywords/microtubule-inhibitors","display_name":"microtubule inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/dna-alkylating-agents","display_name":"DNA alkylating agents","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6412808895111084},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.6409023404121399},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.5860062837600708},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5503439903259277},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5328930616378784},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.48466402292251587},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4632602334022522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4623739421367645},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3942852318286896},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.39269113540649414},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36023691296577454},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3427296280860901},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.16694289445877075},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13909757137298584},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.08885696530342102},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.07120275497436523},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14229/jadc.2019.11.12.001","doi":"https://doi.org/10.14229/jadc.2019.11.12.001","is_oa":true,"landing_page_url":"https://doi.org/10.14229/jadc.2019.11.12.001","pdf_url":null,"source":{"id":"https://openalex.org/S4210211455","display_name":"ADC Review / Journal of Antibody-drug Conjugates","issn_l":"2327-0152","issn":["2327-0152"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ADC Review / Journal of Antibody-drug Conjugates","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.14229/jadc.2019.11.12.001","doi":"https://doi.org/10.14229/jadc.2019.11.12.001","is_oa":true,"landing_page_url":"https://doi.org/10.14229/jadc.2019.11.12.001","pdf_url":null,"source":{"id":"https://openalex.org/S4210211455","display_name":"ADC Review / Journal of Antibody-drug Conjugates","issn_l":"2327-0152","issn":["2327-0152"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ADC Review / Journal of Antibody-drug Conjugates","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2773984687","https://openalex.org/W2976014324"],"related_works":["https://openalex.org/W2143004018","https://openalex.org/W2893386726","https://openalex.org/W4214766446","https://openalex.org/W4361891112","https://openalex.org/W4361891222","https://openalex.org/W4361962275","https://openalex.org/W4387263551","https://openalex.org/W4362541460","https://openalex.org/W4361891228","https://openalex.org/W4387262796"],"abstract_inverted_index":{"The":[0,27],"Antibody-drug":[1],"Conjugate":[2],"(ADC)":[3],"field":[4],"is":[5,36,71],"poised":[6],"for":[7],"several":[8,25],"significant":[9],"advances":[10],"in":[11,75],"solid":[12],"tumors":[13],"as":[14],"the":[15,23,38,43,72,77],"industry":[16],"has":[17],"built":[18],"upon":[19],"knowledge":[20],"gained":[21],"over":[22],"past":[24],"years.":[26],"biggest":[28],"challenge":[29],"facing":[30],"clinical":[31],"translation":[32],"of":[33,45],"these":[34],"drugs":[35],"improving":[37,76],"therapeutic":[39],"index":[40],"(TI).":[41],"With":[42],"use":[44],"proven":[46,52],"targeting":[47],"agents":[48],"(monoclonal":[49],"antibodies)":[50],"and":[51,58],"cancer":[53,65],"cytotoxins":[54],"(e.g.":[55],"microtubule":[56],"inhibitors":[57],"DNA":[59],"alkylating":[60],"agents),":[61],"increasing":[62],"delivery":[63],"to":[64],"cells":[66],"while":[67],"avoiding":[68],"healthy":[69],"tissue":[70],"key":[73],"issue":[74],"TI.":[78]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-05-21T06:26:12.895304","created_date":"2025-10-10T00:00:00"}